A Single Ascending Dose Trial of CVL-936 in Healthy Subjects
Status:
Terminated
Trial end date:
2020-05-21
Target enrollment:
Participant gender:
Summary
The aim of this trial is to investigate the safety, tolerability, pharmacokinetics (PK), and
pharmacodynamics (PD) of CVL-936 following single ascending oral doses in healthy subjects.